Matrix Metalloprotease Inhibitors

 
Cat.No.
Product Name / Activity
2621 ARP 100
Selective inhibitor of MMP-2
2622 ARP 101
Inhibitor of MMP-2
2961 Batimastat
Potent, broad spectrum MMP inhibitor
2632 CL 82198 hydrochloride
Selective inhibitor of MMP-13
3780 CP 471474
Broad spectrum MMP inhibitor
4090 Doxycycline hyclate
Broad-spectrum MMP inhibitor; tetracycline derivative
2983 GM 6001
Broad spectrum MMP inhibitor
2631 Marimastat
Broad spectrum MMP inhibitor
3268 Minocycline hydrochloride
Inhibitor of MMP activity
4902 NSC 405020
Inhibitor of MT1-MMP; antitumor
2628 ONO 4817
Broad spectrum MMP inhibitor
2520 PD 166793
Broad spectrum MMP inhibitor
2916 Ro 32-3555
Potent, collagenase-selective MMP inhibitor
4775 SD 2590 hydrochloride
Potent MMP inhibitor
4187 UK 356618
Potent and selective MMP-3 inhibitor
2900 UK 370106
Highly selective MMP-3 and MMP-12 inhibitor
4188 UK 383367
Potent and selective BMP-1 (PCP) inhibitor
2633 WAY 170523
Potent and selective inhibitor of MMP-13

View all Matrix Metalloprotease products

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Product Guide

Cancer Research Product Guide

Our Cancer Research Guide highlights over 750 products for cancer research. Request copy or view PDF today.

divider line

Neurodegeneration Research Product Guide

Neurodegeneration Product Guide

Our Neurodegeneration guide highlights over 275 products for neurodegeneration research. Request copy or view PDF today.

divider line

VEGF Pathway & Anti-Angiogenic Therapy

Written by N. Ferrara & Y. Crawford

Angiogenesis Life Science Poster

A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance. Request copy today.

divider line

Bio-Techne Events

Pharmacology 2016

Pharmacology 2016

December 13 - 15, 2016

London, UK

Booth: 7